Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV
Health and Human Services, Department of · National Institutes of Health
Combined Synopsis/SolicitationNo set-asideOther Scientific and Technical Consulting Services541690Maryland (MD)Due Jul 30, 2026